Characterization of the Association of Radiolabeled Bleomycin A2 with HeLa Cells

Cancer Research

Volumn 44, Issue 4, 1984, Pages 1541-1546

  Roy, Samar N ^a   Horwitz, Susan Band ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN SULFATE; DNA; RADIOISOTOPE;

BINDING SITE; BLEOMYCIN A2 H 3; BLEOMYCIN COPPER H 3; DRUG BINDING; FEMALE GENITAL SYSTEM; HELA CELL; HUMAN; HUMAN CELL;

ANIMAL; BINDING SITES; BIOLOGICAL TRANSPORT; BLEOMYCIN; CATTLE; CELL NUCLEUS; CHEMISTRY; DNA, NEOPLASM; HELA CELLS; HUMAN; KINETICS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THYMUS GLAND; TRITIUM;

EID: 0021267030     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Akiyama, S., Hidaka, K., Komiyama, S., and Kuwano, M. Control of permeation of bleomycin A2 by polyene antibiotics in cultured Chinese hamster cells. Cancer Res., 39: 5150-5154, 1979.
2. Burger, R. M., Horwitz, S. B., Peisach, J., and Wittenberg, J. B. Oxygenated iron bleomycin: a short-lived intermediate in the reaction of ferrous bleomycin with O2. J. Biol. Chem., 254: 12299-12302, 1979.
3. Burger, R. M., Peisach, J., and Horwitz, S. B. Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. J. Biol. Chem., 256: 11636-11644, 1981.
4. Burger, R. M., Peisach, J., and Horwitz, S. B. Minireview. Mechanism of bleomycin action: in vitro studies. Life Sci., 28: 715-727, 1981.
5. Cerami, A., Reich, E., Ward, D. C., and Goldberg, I. H. The interaction of actinomycin with DNA: requirement for the 2-amino group of purines. Proc. Natl. Acad. Sci. U. S. A., 57: 1036-1042, 1967.
6. Chauveau, J., Moulé, Y., and Rouilller, C. Isolation of pure and unaltered fiver nuclei morphology and biochemical composition. Exptl. Cell Res., 11: 317-321, 1956.
7. Chien, M., Grolman, A. P., and Horwitz, S. B. Bleomycin-DNA interactions: fluorescence and proton magnetic resonance studies. Biochemistry, 16: 3642-3647, 1977.
8. Colowick, S. P., and Womack, F. C. Binding of diffusible molecules by macromolecules: rapid measurement by rate of dialysis. J. Biol. Chem., 244: 774-777, 1969.
9. Crooke, S. T., and Bradner, W. T. Bleomycin: A review. J. Med., 7: 333-427, 1976.
10. Friedman, J. H., Horwitz, S. B., and Peisach, J. Reduction of copper (II)-bleomycin: a model for in Vivo drug activity. Biochemistry, 21: 2203-2210, 1982.
11. Hecht, S. M. Summary of bleomycin symposium. In: S. M. Hecht (ed.), Bleomycin: Chemical. Biochemical, and Biological Aspects, pp. 1-23. New York, Springer-Verlag. 1979.
12. Hori, S., Sawa, T., Yoshioka, T., Takita, T., Takeuchi, T., and Umezawa, H. A metabolite of bleomycin A*** in rabbit urine. J. Antibiot. (Tokyo). 27; 489-491, 1974.
13. Hurley, L. H., Chandler, C., Gamer, T. F., Petrusek, R., and Zimmer, S. G. DNA binding, induction of unscheduled DNA synthesis, and excision of anthramycin from DNA in normal and repair-deficient human fibroblasts. J. Biol. Chem., 254: 605-608, 1979.
14. Kanao, M., Tornita, S., Ishida, S., Murakami, A., and Okada, H. Chelation of bleomycin with copper in vivo. Chemotherapy, 21: 1305-1310, 1973.
15. Miyaki, M., Ono, T., Hori, S., and Umezawa, H. Binding of bleomycin to DNA in bleomycin-Sensitive and -resistant rat ascites hepatoma cells. Cancer Res., 35: 2015-2019. 1975.
16. Nunn, A. D., and Lumec, J. A comparison of the effect of metai-bieomycin complexes on the DNA damage and survival of cultured mammalian cells. Eur. J. Cancer. 14: 857-863. 1978.
17. Rao, E. A., Saryan, L. A., Anthofine, W. E., and Petering, D. H. Cytotoxic and antitumor properties of bleomycin and several of its metal complexes. J. Med. Chem., 23: 1310-1318, 1980.
18. Roy, S. N., Orr, G. A., Brewer, C. F., and Horwitz, S. B. Chemical synthesis of radiolabeled BLMAg and its binding to DNA. Cancer Res., 41: 4471-4477, 1981.
19. Sausville, E. A., Peisach, J., and Horwitz, S. B. Role of ferrous iron and oxygen in the degradation of DNA by bleomycin. Biochem. Biophys. Res. Commun., 73: 814-822, 1976.
20. Sausville, E. A., Stein, R. W., Peisach, J., and Horwitz, S. B. Properties and products of the degradation of DNA by bleomycin and iron (II). Biochemistry, 17: 2746-2754, 1978.
21. Suzuki, H., Nagai, K., Yamaki, H., Tanaka, N., and Umezawa, H. Mechanism of action of bleomycin. Studies with the growing culture of bacterial and tumor cells. J. Antibiot. (Tokyo) Ser. A, 21: 279-286, 1968.
22. Takahashi, K., Yoshioka, O., Matsuda, A., and Umezawa, H. Intracelular reduction of the cupric ion of bleomycin copper complex and transfer of the cuprous ion to a celular protein. J. Antibiot (Tokyo), 30; 861-869, 1977.
23. Uehara, Y., Hori, M., and Umezawa, H. Specificity of transport of bleomycin and cobalt-bleomycin in L5178Y cells. Biochem. Biophys. Res. Commun., 104: 416-421, 1982.
24. Umezawa, H., Meada, K., Takeuchi, T., and Okami, Y. New antibiotics: bleomycin A and B. J. Antibiot. (Tokyo) Ser. A, 19: 200-209, 1966.
25. Umezawa, H., Takeuchi, T., Hori, S., Sawa, T., Ishizuka, M., Ichikawa, T., and Komai, T. Studies on the mechanism of antitumor effect of bleomycin on squamous cell carcinoma. J. Antibiot. (Tokyo) Ser. A, 25: 409-420, 1972.
26. Urano, M., Fukuda, N., and Koike, S. The effect of bleomycin on survival and tumor growth in a C3H mouse mammary carcinoma. Cancer Res., 33: 2849-2855, 1973.